2-(3-(benzo[d]thiazol-2-yl)piperidin-1-yl)-N-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)acetamide

ID: ALA3621954

Chembl Id: CHEMBL3621954

Cas Number: 956571-77-0

PubChem CID: 16358423

Max Phase: Preclinical

Molecular Formula: C25H27N5OS

Molecular Weight: 445.59

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nn(-c2ccccc2)c(C)c1NC(=O)CN1CCCC(c2nc3ccccc3s2)C1

Standard InChI:  InChI=1S/C25H27N5OS/c1-17-24(18(2)30(28-17)20-10-4-3-5-11-20)27-23(31)16-29-14-8-9-19(15-29)25-26-21-12-6-7-13-22(21)32-25/h3-7,10-13,19H,8-9,14-16H2,1-2H3,(H,27,31)

Standard InChI Key:  JKGGFVABTBFVOC-UHFFFAOYSA-N

Associated Targets(Human)

NEDD4 Tchem E3 ubiquitin-protein ligase NEDD4 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.59Molecular Weight (Monoisotopic): 445.1936AlogP: 4.92#Rotatable Bonds: 5
Polar Surface Area: 63.05Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.88CX Basic pKa: 6.79CX LogP: 4.21CX LogD: 4.11
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.47Np Likeness Score: -2.33

References

1. Rognan D.  (2015)  Rational design of proteinprotein interaction inhibitors,  (1): [10.1039/C4MD00328D]

Source